Somatostatin analogue composition and use in treating breast can

Details Somatostatin analogue composition and use in treating breast can Somatostatin analogue composition and use in treating breast can

1998-02-11

2000-05-23

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 9, 530317, A61K 3831

Patent

active

060666161

ABSTRACT:
The invention provides a pharmaceutical composition comprising a somatostatin analogue, and its use in the treatment of breast cancer. The pharmaceutical composition preferably contains lactic acid in addition to the somatostatin analogue and is better tolerated when administered by injection.

REFERENCES:
patent: 4146612 (1979-03-01), Veber
patent: 4328214 (1982-05-01), Rink et al.
patent: 4603120 (1986-07-01), Kamber
patent: 4650787 (1987-03-01), Schally et al.
patent: 4767628 (1988-08-01), Hutchinson
patent: 4900730 (1990-02-01), Miyauchi
patent: 5187150 (1993-02-01), Speiser et al.
patent: 5384309 (1995-01-01), Barber et al.
Cancer Research 47, 1566-1570, Mar. 15, 1987, Buddy Setyono-Han et al., pp. 1566-1570.
Europ. J. Cancer Vol. 27, Suppl. 2, p. S312 Abstr. No. 1920-1991.
J. Cancer Res. Clin. Oncol. Vol. 116 (Supply./Part 1), p. 466, Abstr. No. A4. 123.05-1990.
European Journal of Cancer 1991-Vol. 27, (Suppl. 2). P. S287 (Abs. 1761).
Proceedings of Asco Vol. 12 Mar. 1993-p. 93.

Affiliated with

Also associated with

Rating

Somatostatin analogue composition and use in treating breast can does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Somatostatin analogue composition and use in treating breast can, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatostatin analogue composition and use in treating breast can will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1837144